[Skip to content]

Database

The CASH Database

The database is the hub of the CASH service. The content can be added, searched and exported to create personalised alerting services for library customers.  There are a number of newsfeeds that can be embedded into external CAS website pages keeping them constantly updated with the latest content.

To search for a specific item enter a keyword that may appear in either the title or summary.

Database entry is very quick and easy, see the Database Quick Guide for further support.

Search Tips

  • Search for the first three words in the title e.g. "Five year forward" will find everything about the Five Year Forward View
  • Browse a category from the drop-down list to see the latest news on that topic

  • Enter a keyword to narrow your search e.g. Category Mental Health and Keyword Parity 

Digestive enzymes of fungal origin as a relevant cause of false positive Aspergillus antigen testing in intensive care unit patients, Infection

Source
Infection
Year of publication
2021
Abstract
Background: Galactomannan antigen (GM) testing is widely used in the diagnosis of invasive aspergillosis (IA). Digestive enzymes play an important role in enzyme substitution therapy in exocrine pancreatic insufficiency. As digestive enzymes of fungal origin like Nortase contain enzymes from Aspergillus, a false-positive result of the test might be possible because of cross-reacting antigens of the cell wall of the producing fungi. We, therefore, asked whether the administration of fungal enzymes is a relevant cause of false-positive GM antigen test results. Methods: Patients with a positive GM antigen test between January 2016 and April 2020 were included in the evaluation and divided into two groups: group 1—Nortase-therapy, group 2—no Nortase-therapy. In addition, dissolved Nortase samples were analyzed in vitro for GM and β-1,3-D-glucan. For statistical analysis, the chi-squared and Mann‒Whitney U tests were used. Results: Sixty-five patients were included in this evaluation (30 patients receiving Nortase and 35 patients not receiving Nortase). The overall false positivity rate of GM testing was 43.1%. Notably, false-positive results were detected significantly more often in the Nortase group (73.3%) than in the control group (17.1%, p < 0.001). While the positive predictive value of GM testing was 0.83 in the control group, there was a dramatic decline to 0.27 in the Nortase group. In vitro analysis proved that the Nortase enzyme preparation was highly positive for the fungal antigens GM and β-1,3-D-glucan. Conclusions: Our data demonstrate that the administration of digestive enzymes of fungal origin like Nortase leads to a significantly higher rate of false-positive GM test results compared to that in patients without digestive enzyme treatment.
Date added
13/05/2021
Created by
Sarah Thomas
Published by
Current Awareness Service for Health